Gene expression profiling defines the role of ATP-exposed keratinocytes in skin inflammation

Journal of Dermatological Science

Volumn 58, Issue 2, 2010, Pages 143-151

  Ohara, Hiroshi ^a   Saito, Rumiko ^b   Hirakawa, Satoshi ^b,c   Shimada, Miki ^a   Mano, Nariyasu ^a   Okuyama, Ryuhei ^b   Aiba, Setsuya ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c POLA CHEMICAL INDUSTRIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ADENOSINE TRIPHOSPHATE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; INTERLEUKIN 20; INTERLEUKIN 6; MESSENGER RNA; STAT3 PROTEIN;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KERATINOCYTE; MICROARRAY ANALYSIS; NEUTROPHIL CHEMOTAXIS; NEWBORN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INFLAMMATION; VALIDATION STUDY; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKINS; KERATINOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; STAT3 TRANSCRIPTION FACTOR;

EID: 77952237517     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.02.007     Document Type: Article

References (56)

1. Brake A.J., Julius D. Signaling by extracellular nucleotides. Annu Rev Cell Dev Biol 1996, 12:519-541.
2. Lazarowski E.R., Boucher R.C., Harden T.K. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 2003, 64:785-795.
3. Mizumoto N., Mummert M.E., Shalhevet D., Takashima A. Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J Invest Dermatol 2003, 121:1066-1072.
4. 2+ waves in keratinocytes are transmitted to sensory neurons: the involvement of extracellular ATP and P2Y2 receptor activation. Biochem J 2004, 380:329-338.
5. Burnstock G. Purine and pyrimidine receptors. Cell Mol Life Sci 2007, 64:1471-1483.
6. Burnstock G., Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 2004, 240:31-304.
7. Di Virgilio F., Chiozzi P., Ferrari D., Falzoni S., Sanz J.M., Morelli A., et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001, 97:587-600.
8. Cotrina M.L., Lin J.H., Alves-Rodrigues A., Liu S., Li J., Azmi-Ghadimi H., et al. Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA 1998, 95:15735-15740.
9. Ferrari D., Chiozzi P., Falzoni S., Hanau S., Di Virgilio F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med 1997, 185:579-582.
10. Lazarowski E.R., Homolya L., Boucher R.C., Harden T.K. Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation. J Biol Chem 1997, 272:24348-24354.
11. Roman R.M., Wang Y., Lidofsky S.D., Feranchak A.P., Lomri N., Scharschmidt B.F., et al. Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume. J Biol Chem 1997, 272:21970-21976.
12. Hamada K., Takuwa N., Yokoyama K., Takuwa Y. Stretch activates Jun N-terminal kinase/stress-activated protein kinase in vascular smooth muscle cells through mechanisms involving autocrine ATP stimulation of purinoceptors. J Biol Chem 1998, 273:6334-6340.
13. Mitchell C.H., Carre D.A., McGlinn A.M., Stone R.A., Civan M.M. A release mechanism for stored ATP in ocular ciliary epithelial cells. Proc Natl Acad Sci USA 1998, 95:7174-7178.
14. Pillai S., Bikle D.D. Adenosine triphosphate stimulates phosphoinositide metabolism, mobilizes intracellular calcium, and inhibits terminal differentiation of human epidermal keratinocytes. J Clin Invest 1992, 90:42-51.
15. Dixon C.J., Bowler W.B., Littlewood-Evans A., Dillon J.P., Bilbe G., Sharpe G.R., et al. Regulation of epidermal homeostasis through P2Y2 receptors. Br J Pharmacol 1999, 127:1680-1686.
16. Greig A.V., Linge C., Terenghi G., McGrouther D.A., Burnstock G. Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J Invest Dermatol 2003, 120:1007-1015.
17. Burrell H.E., Bowler W.B., Gallagher J.A., Sharpe G.R. Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors. J Invest Dermatol 2003, 120:440-447.
18. Inoue K., Denda M., Tozaki H., Fujishita K., Koizumi S. Characterization of multiple P2X receptors in cultured normal human epidermal keratinocytes. J Invest Dermatol 2005, 124:756-763.
19. Inoue K., Hosoi J., Denda M. Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes. J Invest Dermatol 2007, 127:362-371.
20. Pastore S., Mascia F., Gulinelli S., Forchap S., Dattilo C., Adinolfi E., et al. Stimulation of purinergic receptors modulates chemokine expression in human keratinocytes. J Invest Dermatol 2007, 127:660-667.
21. Bulanova E., Budagian V., Orinska Z., Koch-Nolte F., Haag F., Bulfone-Paus S. ATP induces P2X7 receptor-independent cytokine and chemokine expression through P2X1 and P2X3 receptors in murine mast cells. J Leukoc Biol 2009, 85:692-702.
22. Seiffert K., Ding W., Wagner J.A., Granstein R.D. ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol 2006, 126:1017-1027.
23. Holzer A.M., Granstein R.D. Role of extracellular adenosine triphosphate in human skin. J Cutan Med Surg 2004, 8:90-96.
24. Murray P.J. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007, 178:2623-2629.
25. Hodge D.R., Hurt E.M., Farrar W.L. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005, 41:2502-2512.
26. Sa S.M., Valdez P.A., Wu J., Jung K., Zhong F., Hall L., et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 2007, 178:2229-2240.
27. Dumoutier L., Leemans C., Lejeune D., Kotenko S.V., Renauld J.C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 2001, 167:3545-3549.
28. Blumberg H., Conklin D., Xu W.F., Grossmann A., Brender T., Carollo S., et al. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 2001, 104:9-19.
29. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
30. Gilchrist M., Thorsson V., Li B., Rust A.G., Korb M., Roach J.C., et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006, 441:173-178.
31. Yan C., Lu D., Hai T., Boyd D.D. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J 2005, 24:2425-2435.
32. Kawauchi J., Zhang C., Nobori K., Hashimoto Y., Adachi M.T., Noda A., et al. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J Biol Chem 2002, 277:39025-39034.
33. Hartman M.G., Lu D., Kim M.L., Kociba G.J., Shukri T., Buteau J., et al. Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell Biol 2004, 24:5721-5732.
34. Whitmore M.M., Iparraguirre A., Kubelka L., Weninger W., Hai T., Williams B.R. Negative regulation of TLR-signaling pathways by activating transcription factor-3. J Immunol 2007, 179:3622-3630.
35. Piccini A., Carta S., Tassi S., Lasiglie D., Fossati G., Rubartelli A. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA 2008, 105:8067-8072.
36. Watanabe H., Gaide O., Petrilli V., Martinon F., Contassot E., Roques S., et al. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 2007, 127:1956-1963.
37. Washburn K.B., Neary J.T. P2 purinergic receptors signal to STAT3 in astrocytes: difference in STAT3 responses to P2Y and P2X receptor activation. Neuroscience 2006, 142:411-423.
38. Sano S., Chan K.S., DiGiovanni J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci 2008, 50:1-14.
39. Sano S., Chan K.S., Carbajal S., Clifford J., Peavey M., Kiguchi K., et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005, 11:43-49.
40. Wei C.C., Chen W.Y., Wang Y.C., Chen P.J., Lee J.Y., Wong T.W., et al. Detection of IL-20 and its receptors on psoriatic skin. Clin Immunol 2005, 117:65-72.
41. Wang F., Lee E., Lowes M.A., Haider A.S., Fuentes-Duculan J., Abello M.V., et al. Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: gene regulation and cellular effects. J Invest Dermatol 2006, 126:1590-1599.
42. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254.
43. Wolk K., Haugen H.S., Xu W., Witte E., Waggie K., Anderson M., et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med 2009, 87:523-536.
44. Weiss G., Shemer A., Trau H. The Koebner phenomenon: review of the literature. J Eur Acad Dermatol Venereol 2002, 16:241-248.
45. Hai T., Wolfgang C.D., Marsee D.K., Allen A.E., Sivaprasad U. ATF3 and stress responses. Gene Exp 1999, 7:321-335.
46. Hai T., Hartman M.G. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001, 273:1-11.
47. Lu D., Wolfgang C.D., Hai T. Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J Biol Chem 2006, 281:10473-10481.
48. Lu D., Chen J., Hai T. The regulation of ATF3 gene expression by mitogen-activated protein kinases. Biochem J 2007, 401:559-567.
49. Bottone F.G., Moon Y., Alston-Mills B., Eling T.E. Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene. J Pharmacol Exp Ther 2005, 315:668-677.
50. Miller L.S., Modlin R.L. Human keratinocyte Toll-like receptors promote distinct immune responses. J Invest Dermatol 2007, 127:262-263.
51. Zhao X., Town J.R., Li F., Zhang X., Cockcroft D.W., Gordon J.R. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. J Immunol 2009, 182:3213-3222.
52. Devalaraja R.M., Nanney L.B., Du J., Qian Q., Yu Y., Devalaraja M.N., et al. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 2000, 115:234-244.
53. Reich K., Garbe C., Blaschke V., Maurer C., Middel P., Westphal G., et al. Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation. J Invest Dermatol 2001, 116:319-329.
54. Anttila H.S., Reitamo S., Erkko P., Ceska M., Moser B., Baggiolini M. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. J Invest Dermatol 1992, 98:96-101.
55. Barker C.L., McHale M.T., Gillies A.K., Waller J., Pearce D.M., Osborne J., et al. The development and characterization of an in vitro model of psoriasis. J Invest Dermatol 2004, 123:892-901.
56. Steude J., Kulke R., Christophers E. Interleukin-1-stimulated secretion of interleukin-8 and growth-related oncogene-alpha demonstrates greatly enhanced keratinocyte growth in human raft cultured epidermis. J Invest Dermatol 2002, 119:1254-1260.